Who is accountable when a vendor privileged session is abused?

Why This Matters for Security Teams

Vendor privileged session are high-risk because the session may be operated by an external party, but the trust boundary still sits inside the healthcare organisation. If that session is abused, the issue is usually not just misuse by the vendor; it is also a governance failure in approval, scope, monitoring, and revocation. That is why the organisation cannot outsource accountability, even when access is delegated.

The practical danger is that third-party access often grows beyond its original purpose. NHIMG notes that 92% of organisations expose NHIs to third parties, which makes vendor access a supply chain issue as much as an access control issue, as discussed in the Ultimate Guide to NHIs — Key Challenges and Risks. If privileged sessions are not tied to a named internal owner, an expiry condition, and a review workflow, they become difficult to defend after the fact. The OWASP Non-Human Identity Top 10 also reinforces that unmanaged non-human access is a control failure, not just an incident response problem.

In practice, many security teams encounter vendor session abuse only after logs, patient systems, or administrative data have already been touched, rather than through intentional access governance.

How It Works in Practice

The cleanest accountability model is simple: the vendor may execute the task, but the healthcare organisation owns the decision to grant access and the obligation to supervise it. That means internal accountability should be assigned to a system owner, application owner, or service owner who can approve scope, confirm necessity, and revoke access quickly when the task ends. A shared mailbox or generic helpdesk queue is not enough.

Operationally, the session should be issued with tightly bounded scope, recorded, and reviewed against the reason for access. Strong programs combine privileged access management, ticket linkage, session recording, and time-bounded credentials. That aligns with current guidance in the Ultimate Guide to NHIs — The NHI Market, which emphasizes lifecycle control rather than one-time approval. The most effective teams also require:

• named internal owner for every vendor session
• JIT approval with a defined expiration time
• task-specific least privilege, not broad admin standing access
• session logging, alerting, and post-session review
• immediate revocation path if behaviour deviates from the approved scope

For implementation, NIST Zero Trust guidance and the NIST SP 800-207 Zero Trust Architecture support continuous verification rather than trust based on vendor status alone, while the NIST AI Risk Management Framework is useful where AI-assisted operations or automated support tools participate in approval or monitoring. These controls tend to break down when vendors share credentials, sessions are not individually attributable, or emergency access is left permanently enabled.

Common Variations and Edge Cases

Tighter vendor session control often increases operational overhead, requiring organisations to balance emergency responsiveness against auditability and containment. That tradeoff becomes especially visible in clinical environments, where downtime pressure can tempt teams to create permanent break-glass access that later turns into routine access.

Current guidance suggests a few important distinctions. A vendor using a monitored JIT session is not the same as a vendor using a shared admin account, and a supervised remote support session is not the same as a standing integration credential. The first can be defensible if ownership, logging, and revocation are strong; the second is usually a governance failure. Where policy is immature, the internal owner should be the one to decide whether the vendor gets access at all, and to confirm that the access remains tied to a specific ticket, patient-safe maintenance window, or approved change.

In healthcare, there are also edge cases involving subcontractors, managed service providers, and tool vendors that access systems indirectly. In those cases, accountability still remains with the healthcare organisation for the access it authorises, even if downstream execution is outsourced. The best practice is evolving, but the core principle is stable: delegated access must remain reviewable, attributable, and revocable. See also the OWASP view of non-human identity risk in the OWASP Non-Human Identity Top 10 and NHIMG’s broader risk framing in the Ultimate Guide to NHIs — Key Challenges and Risks.

Related resources from NHI Mgmt Group

• Who is accountable when a time-boxed privileged session is abused?
• Who is accountable when a privileged session is abused after credential checkout?
• Who is accountable when a contractor or vendor is misidentified?
• Who is accountable when a vendor OAuth grant is abused?